Meet the Experts

Portrait of Robert L. Coleman
Biography Disclosures

Dr Robert L. Coleman

Go Back

Gynaecologic Oncologist

  • US Oncology Research
  • location United States
Biography Disclosures
Dr Robert L. Coleman has received financial support/sponsorship for research support, consultation, or speaker fees from the following companies:

Amgen, Aravive, ArQuel, Cell Medica, Clovis, Geistlich Pharma, Genetech, GenMab, ImmunoGen, Janssen, Medscape, Merck, Mersana, MoreHealth, OncLive, OncoMed, Physicians Educational Resource, Takeda, Tesaro, TRM Oncology and United Therapeutics. 

Programmes developed by Dr Robert L. Coleman

Understand the mechanism of action of PARP inhibitors and targeting DNA Damage Response (DDR): A short video » COR2ED Video
Oncology 
Understand the MoA of PARP inhibitors and targeting DNA Damage Response (DDR)

Experts
Dr Robert L. Coleman, Prof. Simon Boulton
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Sep 2021
COR2ED
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca
E-learning The role of PARP inhibition in clinical practice » COR2ED Interactive e-learning
Oncology 
The Role of PARP Inhibition in Clinical Practice

Experts
Prof. Jonathan A. Ledermann, Dr Rebecca Dent, Dr Robert L. Coleman, Prof. Eric Pujade-Lauraine
  • clock 60 MIN
  • calendar Sep 2021
COR2ED EACCME
This educational programme is supported by an Independent Medical Education Grant from AstraZeneca
Explore all our programmes